Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Tumor thrombus in the venous drainage pathways of primary, recurrent and metastatic disease on routine oncologic imaging studies: beyond hepatocellular and renal cell carcinomas.

Yedururi S, Kang H, Cox VL, Chawla S, Le O, Loyer EM, Marcal L.

Br J Radiol. 2019 Jun;92(1098):20180478. doi: 10.1259/bjr.20180478. Epub 2019 Apr 24.

PMID:
30844299
2.

Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases.

Lee AJ, Loyer EM, Kang HC, Aloia TA, Tzeng CD, Vauthey JN, Chun YS.

Ann Surg Oncol. 2019 Jan;26(1):275-281. doi: 10.1245/s10434-018-6945-0. Epub 2018 Oct 25.

PMID:
30362064
3.

The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia.

Overman MJ, Ferrarotto R, Raghav K, George B, Qiao W, Machado KK, Saltz LB, Mazard T, Vauthey JN, Hoff PM, Hobbs B, Loyer EM, Kopetz S.

J Natl Cancer Inst. 2018 Aug 1;110(8):888-894. doi: 10.1093/jnci/djx288.

PMID:
29346573
4.

Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab.

Mazard T, Boonsirikamchai P, Overman MJ, Asran MA, Choi H, Herron D, Eng C, Maru DM, Ychou M, Vauthey JN, Loyer EM, Kopetz S.

Gut. 2018 Jun;67(6):1095-1102. doi: 10.1136/gutjnl-2017-313786. Epub 2017 Oct 30.

PMID:
29084828
5.

Radiofrequency Ablation of Hepatic Tumor: Subjective Assessment of the Perilesional Vascular Network on Contrast-Enhanced Computed Tomography Before and After Ablation Can Reliably Predict the Risk of Local Recurrence.

Yedururi S, Terpenning S, Gupta S, Fox P, Martin SS, Conrad C, Loyer EM.

J Comput Assist Tomogr. 2017 Jul/Aug;41(4):607-613. doi: 10.1097/RCT.0000000000000562.

6.

Quantitation of clinical feedback on image quality differences between two CT scanner models.

Bache ST, Stauduhar PJ, Liu X, Loyer EM, John RX.

J Appl Clin Med Phys. 2017 Mar;18(2):163-169. doi: 10.1002/acm2.12050. Epub 2017 Mar 1.

7.

(18)F-FDG Uptake at the Surgical Margin after Hepatic Resection: Patterns of Uptake and Differential Diagnosis.

Peungjesada S, Aloia TA, Fox P, Chasen B, Shin S, Baiomy A, Loyer EM.

Eur Radiol. 2015 Aug;25(8):2453-9. doi: 10.1007/s00330-015-3631-5. Epub 2015 Feb 13.

PMID:
25678079
8.

RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases.

Zimmitti G, Shindoh J, Mise Y, Kopetz S, Loyer EM, Andreou A, Cooper AB, Kaur H, Aloia TA, Maru DM, Vauthey JN.

Ann Surg Oncol. 2015 Mar;22(3):834-842. doi: 10.1245/s10434-014-4042-6. Epub 2014 Sep 17.

9.

Efficacy and safety of portal vein embolization for two-stage hepatectomy in patients with colorectal liver metastasis.

Huang SY, Aloia TA, Shindoh J, Ensor J, Shaw CM, Loyer EM, Vauthey JN, Wallace MJ.

J Vasc Interv Radiol. 2014 Apr;25(4):608-17. doi: 10.1016/j.jvir.2013.10.028. Epub 2013 Dec 5.

PMID:
24315549
10.

Intrabiliary growth of colorectal liver metastasis: spectrum of imaging findings and implications for surgical management.

Peungjesada S, Aloia TA, Kaur H, Marcal L, Choi H, Vauthey JN, Loyer EM.

AJR Am J Roentgenol. 2013 Oct;201(4):W582-9. doi: 10.2214/AJR.12.9508.

PMID:
24059396
11.

Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction.

Hassan MM, Kaseb A, Etzel CJ, El-Serag H, Spitz MR, Chang P, Hale KS, Liu M, Rashid A, Shama M, Abbruzzese JL, Loyer EM, Kaur H, Hassabo HM, Vauthey JN, Wray CJ, Hassan BS, Patt YZ, Hawk E, Soliman KM, Li D.

Mol Carcinog. 2013 Nov;52 Suppl 1:E139-47. doi: 10.1002/mc.22057. Epub 2013 Jun 15.

12.
13.

Evaluation of cancer treatment in the abdomen: Trends and advances.

Peungjesada S, Chuang HH, Prasad SR, Choi H, Loyer EM, Bronstein Y.

World J Radiol. 2013 Mar 28;5(3):126-42. doi: 10.4329/wjr.v5.i3.126.

14.

Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy.

Andreou A, Aloia TA, Brouquet A, Dickson PV, Zimmitti G, Maru DM, Kopetz S, Loyer EM, Curley SA, Abdalla EK, Vauthey JN.

Ann Surg. 2013 Jun;257(6):1079-88. doi: 10.1097/SLA.0b013e318283a4d1.

15.

SSAT/AHPBA joint symposium on evaluation and treatment of benign liver lesions.

Chun YS, House MG, Kaur H, Loyer EM, Paradis V, Vauthey JN.

J Gastrointest Surg. 2013 Apr;17(4):636-44. doi: 10.1007/s11605-013-2153-1. Epub 2013 Feb 2. No abstract available.

16.

Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases.

Shindoh J, Loyer EM, Kopetz S, Boonsirikamchai P, Maru DM, Chun YS, Zimmitti G, Curley SA, Charnsangavej C, Aloia TA, Vauthey JN.

J Clin Oncol. 2012 Dec 20;30(36):4566-72. doi: 10.1200/JCO.2012.45.2854. Epub 2012 Nov 13.

17.

Case 177: Congenital absence of the portal vein with hepatic adenomatosis.

Asran MK, Loyer EM, Kaur H, Choi H.

Radiology. 2012 Jan;262(1):364-7. doi: 10.1148/radiol.11102046. No abstract available.

PMID:
22190661
18.

CT findings of response and recurrence, independent of change in tumor size, in colorectal liver metastasis treated with bevacizumab.

Boonsirikamchai P, Asran MA, Maru DM, Vauthey JN, Kaur H, Kopetz S, Loyer EM.

AJR Am J Roentgenol. 2011 Dec;197(6):W1060-6. doi: 10.2214/AJR.11.6459. Review.

PMID:
22109320
19.

Hepatectomy for recurrent colorectal liver metastases after radiofrequency ablation.

Brouquet A, Vauthey JN, Badgwell BD, Loyer EM, Kaur H, Curley SA, Abdalla EK.

Br J Surg. 2011 Jul;98(7):1003-9. doi: 10.1002/bjs.7506. Epub 2011 May 3.

20.

Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified?

Brouquet A, Overman MJ, Kopetz S, Maru DM, Loyer EM, Andreou A, Cooper A, Curley SA, Garrett CR, Abdalla EK, Vauthey JN.

Cancer. 2011 Oct 1;117(19):4484-92. doi: 10.1002/cncr.26036. Epub 2011 Mar 28.

21.

Planning and follow-up after ablation of hepatic tumors: imaging evaluation.

Boonsirikamchai P, Loyer EM, Choi H, Charnsangavej C.

Surg Oncol Clin N Am. 2011 Apr;20(2):301-15, viii. doi: 10.1016/j.soc.2010.11.007. Epub 2010 Dec 16. Review.

PMID:
21377585
22.

High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome.

Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, Andreou A, Loyer EM, Madoff DC, Curley SA, Vauthey JN.

J Clin Oncol. 2011 Mar 10;29(8):1083-90. doi: 10.1200/JCO.2010.32.6132. Epub 2011 Jan 24.

23.

Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases.

Maru DM, Kopetz S, Boonsirikamchai P, Agarwal A, Chun YS, Wang H, Abdalla EK, Kaur H, Charnsangavej C, Vauthey JN, Loyer EM.

Am J Surg Pathol. 2010 Sep;34(9):1287-94. doi: 10.1097/PAS.0b013e3181eb2f7b.

PMID:
20697255
24.

Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury.

Overman MJ, Maru DM, Charnsangavej C, Loyer EM, Wang H, Pathak P, Eng C, Hoff PM, Vauthey JN, Wolff RA, Kopetz S.

J Clin Oncol. 2010 May 20;28(15):2549-55. doi: 10.1200/JCO.2009.27.5701. Epub 2010 Apr 20.

PMID:
20406923
25.

Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.

Chun YS, Vauthey JN, Boonsirikamchai P, Maru DM, Kopetz S, Palavecino M, Curley SA, Abdalla EK, Kaur H, Charnsangavej C, Loyer EM.

JAMA. 2009 Dec 2;302(21):2338-44. doi: 10.1001/jama.2009.1755.

26.

Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.

Wang M, Oki Y, Pro B, Romaguera JE, Rodriguez MA, Samaniego F, McLaughlin P, Hagemeister F, Neelapu S, Copeland A, Samuels BI, Loyer EM, Ji Y, Younes A.

J Clin Oncol. 2009 Nov 1;27(31):5213-8. doi: 10.1200/JCO.2009.21.8545. Epub 2009 Sep 21.

PMID:
19770379
27.

Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer.

Tamm EP, Loyer EM, Faria SC, Evans DB, Wolff RA, Charnsangavej C.

Abdom Imaging. 2007 Sep-Oct;32(5):660-7.

PMID:
17712589
28.

Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome.

Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN.

Br J Surg. 2007 Nov;94(11):1386-94.

PMID:
17583900
29.

Radiologic findings in taxane induced colitis.

Kaur H, Loyer EM, David CL, Sawaf H, DuBrow RA, Ibrahim NK.

Eur J Radiol. 2008 Apr;66(1):75-8. Epub 2007 Jun 5.

PMID:
17553645
30.

Portal thrombosis and steatosis after preoperative chemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases.

Donadon M, Vauthey JN, Loyer EM, Charnsangavej C, Abdalla EK.

World J Gastroenterol. 2006 Oct 28;12(40):6556-8.

31.

Solitary colorectal liver metastasis: resection determines outcome.

Aloia TA, Vauthey JN, Loyer EM, Ribero D, Pawlik TM, Wei SH, Curley SA, Zorzi D, Abdalla EK.

Arch Surg. 2006 May;141(5):460-6; discussion 466-7.

PMID:
16702517
32.

Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib.

Hong X, Choi H, Loyer EM, Benjamin RS, Trent JC, Charnsangavej C.

Radiographics. 2006 Mar-Apr;26(2):481-95. Review.

PMID:
16549611
33.

Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy.

Tamm EP, Loyer EM, Faria S, Raut CP, Evans DB, Wolff RA, Crane CH, Dubrow RA, Charnsangavej C.

Abdom Imaging. 2006 Sep-Oct;31(5):568-74. Epub 2006 Feb 7.

PMID:
16465578
34.

Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN.

Ann Surg. 2005 May;241(5):715-22, discussion 722-4.

35.

Transdiaphragmatic radiofrequency ablation of liver tumors.

Mullen JT, Walsh GL, Abdalla EK, Loyer EM, Curley SA, Vauthey JN.

J Am Coll Surg. 2004 Nov;199(5):826-9. No abstract available.

PMID:
15501127
36.

Neoplasms of the liver and the bile ducts.

Choi H, Loyer EM, Charnsangavej C.

Semin Roentgenol. 2004 Jul;39(3):412-27. Review. No abstract available.

PMID:
15372754
37.

Diagnosis and staging of pancreatic tumors.

Faria SC, Tamm EP, Loyer EM, Szklaruk J, Choi H, Charnsangavej C.

Semin Roentgenol. 2004 Jul;39(3):397-411. Review. No abstract available.

PMID:
15372753
38.

Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease.

Younes A, Pro B, Robertson MJ, Flinn IW, Romaguera JE, Hagemeister F, Dang NH, Fiumara P, Loyer EM, Cabanillas FF, McLaughlin PW, Rodriguez MA, Samaniego F.

Clin Cancer Res. 2004 Aug 15;10(16):5432-8.

39.

Detection of small pancreatic tumors with multiphasic helical CT.

Bronstein YL, Loyer EM, Kaur H, Choi H, David C, DuBrow RA, Broemeling LD, Cleary KR, Charnsangavej C.

AJR Am J Roentgenol. 2004 Mar;182(3):619-23.

PMID:
14975959
40.

Body surface area and body weight predict total liver volume in Western adults.

Vauthey JN, Abdalla EK, Doherty DA, Gertsch P, Fenstermacher MJ, Loyer EM, Lerut J, Materne R, Wang X, Encarnacion A, Herron D, Mathey C, Ferrari G, Charnsangavej C, Do KA, Denys A.

Liver Transpl. 2002 Mar;8(3):233-40.

41.

Cystic lymphangioma of the pancreas.

Koenig TR, Loyer EM, Whitman GJ, Raymond AK, Charnsangavej C.

AJR Am J Roentgenol. 2001 Nov;177(5):1090. No abstract available.

PMID:
11641176
42.

Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications.

Choi H, Loyer EM, DuBrow RA, Kaur H, David CL, Huang S, Curley S, Charnsangavej C.

Radiographics. 2001 Oct;21 Spec No:S41-54.

PMID:
11598247
43.

Imaging of ovarian carcinoma.

Loyer EM, Whitman GJ, Fenstermacher MJ.

Int J Gynecol Cancer. 1999 Sep;9(5):351-361. No abstract available.

PMID:
11240793
44.

Tumors of the liver, bile duct, and pancreas.

Charnsangavej C, Loyer EM, Iyer RB, Choi H, Kaur H.

Curr Probl Diagn Radiol. 2000 May-Jun;29(3):69-107. Review. No abstract available.

PMID:
10875047
45.

Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT--a comparative study.

Loyer EM, Chin H, DuBrow RA, David CL, Eftekhari F, Charnsangavej C.

Radiology. 1999 Sep;212(3):866-75.

PMID:
10478259
46.

Metastases to the pancreas from renal cell carcinoma: findings on three-phase contrast-enhanced helical CT.

Ng CS, Loyer EM, Iyer RB, David CL, DuBrow RA, Charnsangavej C.

AJR Am J Roentgenol. 1999 Jun;172(6):1555-9.

PMID:
10350288
47.

Patterns of uterine enhancement with helical CT.

Kaur H, Loyer EM, Minami M, Charnsangavej C.

Eur J Radiol. 1998 Oct;28(3):250-5.

PMID:
9881261
48.

Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT.

Loyer EM, David CL, Dubrow RA, Evans DB, Charnsangavej C.

Abdom Imaging. 1996 May-Jun;21(3):202-6.

PMID:
8661548
49.

Radiation change in normal organs: an overview of body imaging.

Libshitz HI, DuBrow RA, Loyer EM, Charnsangavej C.

Eur Radiol. 1996;6(6):786-95. Review.

PMID:
8972312
50.

Imaging of superficial soft-tissue infections: sonographic findings in cases of cellulitis and abscess.

Loyer EM, DuBrow RA, David CL, Coan JD, Eftekhari F.

AJR Am J Roentgenol. 1996 Jan;166(1):149-52.

PMID:
8571865

Supplemental Content

Loading ...
Support Center